646 related articles for article (PubMed ID: 7973772)
21. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
22. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
26. Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study.
Adam Z; Coupková H; Kolek V; Kucera M; Loffelmann L; Martinez A; Nováková M; Průsa P; Reiterer P; Skalová B
Acta Med Austriaca; 1995; 22(5):120-4. PubMed ID: 8651041
[TBL] [Abstract][Full Text] [Related]
27. Continuous infusion cisplatin and 5-fluorouracil with bolus vinorelbine in the treatment of advanced nonsmall cell carcinoma of the lung.
Beuzeboc P; Livartowski A; Dierick A; Paraiso D; Pouillart P
J Infus Chemother; 1995; 5(4):193-4. PubMed ID: 8934725
[TBL] [Abstract][Full Text] [Related]
28. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
29. Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.
Fumoleau P; Delozier T; Extra JM; Canobbio L; Delgado FM; Hurteloup P
Semin Oncol; 1995 Apr; 22(2 Suppl 5):22-8; discussion 28-9. PubMed ID: 7740332
[TBL] [Abstract][Full Text] [Related]
30. Current management of unresectable non-small cell lung cancer.
Livingston RB
Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
[TBL] [Abstract][Full Text] [Related]
31. A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (Navelbine): study design and goals.
Havlin K
Semin Oncol; 1995 Apr; 22(2 Suppl 5):38-40; discussion 41-4. PubMed ID: 7537912
[TBL] [Abstract][Full Text] [Related]
32. A summary of vinorelbine (Navelbine) safety data from North American clinical trials.
Hohneker JA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769
[TBL] [Abstract][Full Text] [Related]
33. A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.
Pallis AG; Chandrinos V; Pavlakou G; Xenidis N; Varthalitis I; Vardakis N; Vamvakas L; Kontopodis E; Rovithi M; Georgoulias V
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1239-45. PubMed ID: 20697712
[TBL] [Abstract][Full Text] [Related]
34. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
35. Measuring quality of life: an emerging science.
Moinpour CM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770
[TBL] [Abstract][Full Text] [Related]
36. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Winer EP; Chu L; Spicer DV
Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
[TBL] [Abstract][Full Text] [Related]
37. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Wakelee HA; Middleton G; Dunlop D; Ramlau R; Leighl N; Hao D; Lopez-Anaya A; Zatloukal P; Jacobs CD
Cancer Chemother Pharmacol; 2012 Mar; 69(3):815-24. PubMed ID: 22057854
[TBL] [Abstract][Full Text] [Related]
38. Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.
Hochster HS
Semin Oncol; 1995 Apr; 22(2 Suppl 5):55-9; discussion 59-60. PubMed ID: 7740334
[TBL] [Abstract][Full Text] [Related]
39. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
Vogel CL
Semin Oncol; 1995 Apr; 22(2 Suppl 5):61-5. PubMed ID: 7740335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]